Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Ms. Carrie L. Bourdow$6.5M
Market Cap • 19/04/20242007
(há 17 anos)
2014
(10 years ago)
NASDAQ
Listagem
Chesterbrook
Sede • Pennsylvania35
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TRVNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.